Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole
Identifieur interne : 001428 ( PascalFrancis/Checkpoint ); précédent : 001427; suivant : 001429Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole
Auteurs : A. Boireau [France] ; M. Meunier [France] ; A. Imperato [France]Source :
- Journal of pharmacy and pharmacology [ 0022-3573 ] ; 1998.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Calcium.
English descriptors
- KwdEn :
Abstract
We have examined the effects of riluzole, a neuroprotective drug which stabilizes voltage-dependent sodium channels in their inactivated state and inhibits the release of glutamate in-vivo and in-vitro, on the release of newly taken up [3H]dopamine induced by ouabain, a potent and selective inhibitor of Na+/K+-ATPase in mouse striatal slices in-vitro. Riluzole potently (IC50 (concentration resulting in 50% inhibition)=0.9±0.3 μM) and dose-dependently antagonized ouabain-stimulated [3H]dopamine release, the effect being observed at low concentrations. Tetrodotoxin (1 μM) and nomifensine (10 μM) also abolished ouabain-induced [3H]dopamine release. Blockade of glutamate receptors with dizocilpine (1 μM) and 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (YM-90K; 10 μM), alone or in combination, was without effect. Incubation of striatal slices with 50 μM La3+, which blocks voltage-dependent calcium channels, did not inhibit [3H]dopamine release induced by ouabain. The potent effects of riluzole observed in this model are probably related to its ability to block voltage-dependent sodium channels. The consequences of this activity are critically discussed in relation to the protective action of riluzole previously reported in various models of Parkinson's disease and other neurodegenerative disorders.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:99-0043435Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole</title>
<author><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A." last="Boireau">A. Boireau</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer S. A., Centre de Recherche de Vitry-Alfortville, 13, quai Jules Guesde BP 14</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Vitry-sur-Seine</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M." last="Meunier">M. Meunier</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer S. A., Centre de Recherche de Vitry-Alfortville, 13, quai Jules Guesde BP 14</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Vitry-sur-Seine</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Imperato, A" sort="Imperato, A" uniqKey="Imperato A" first="A." last="Imperato">A. Imperato</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer S. A., Centre de Recherche de Vitry-Alfortville, 13, quai Jules Guesde BP 14</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Vitry-sur-Seine</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0043435</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 99-0043435 INIST</idno>
<idno type="RBID">Pascal:99-0043435</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001555</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001A90</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001428</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001428</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole</title>
<author><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A." last="Boireau">A. Boireau</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer S. A., Centre de Recherche de Vitry-Alfortville, 13, quai Jules Guesde BP 14</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Vitry-sur-Seine</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M." last="Meunier">M. Meunier</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer S. A., Centre de Recherche de Vitry-Alfortville, 13, quai Jules Guesde BP 14</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Vitry-sur-Seine</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Imperato, A" sort="Imperato, A" uniqKey="Imperato A" first="A." last="Imperato">A. Imperato</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer S. A., Centre de Recherche de Vitry-Alfortville, 13, quai Jules Guesde BP 14</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Vitry-sur-Seine</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of pharmacy and pharmacology</title>
<title level="j" type="abbreviated">J. pharm. pharmacol.</title>
<idno type="ISSN">0022-3573</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of pharmacy and pharmacology</title>
<title level="j" type="abbreviated">J. pharm. pharmacol.</title>
<idno type="ISSN">0022-3573</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term>
<term>Anticonvulsant</term>
<term>Benzothiazole</term>
<term>Biological activity</term>
<term>Calcium</term>
<term>Calcium antagonist</term>
<term>Catecholamine</term>
<term>Central nervous system</term>
<term>Corpus striatum</term>
<term>Dopamine</term>
<term>In vitro</term>
<term>Ionic channel</term>
<term>Mechanism of action</term>
<term>Mouse</term>
<term>Neuroprotective agent</term>
<term>Neurotransmitter</term>
<term>Psychotropic</term>
<term>Riluzole</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Riluzole</term>
<term>Anticonvulsivant</term>
<term>Psychotrope</term>
<term>Activité biologique</term>
<term>Mécanisme action</term>
<term>Animal</term>
<term>Souris</term>
<term>Système nerveux central</term>
<term>Corps strié</term>
<term>In vitro</term>
<term>Dopamine</term>
<term>Catécholamine</term>
<term>Neurotransmetteur</term>
<term>Antagoniste calcium</term>
<term>Neuroprotecteur</term>
<term>Canal ionique</term>
<term>Calcium</term>
<term>Benzothiazole</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Calcium</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We have examined the effects of riluzole, a neuroprotective drug which stabilizes voltage-dependent sodium channels in their inactivated state and inhibits the release of glutamate in-vivo and in-vitro, on the release of newly taken up [<sup>3</sup>
H]dopamine induced by ouabain, a potent and selective inhibitor of Na<sup>+</sup>
/K<sup>+</sup>
-ATPase in mouse striatal slices in-vitro. Riluzole potently (IC50 (concentration resulting in 50% inhibition)=0.9±0.3 μM) and dose-dependently antagonized ouabain-stimulated [<sup>3</sup>
H]dopamine release, the effect being observed at low concentrations. Tetrodotoxin (1 μM) and nomifensine (10 μM) also abolished ouabain-induced [<sup>3</sup>
H]dopamine release. Blockade of glutamate receptors with dizocilpine (1 μM) and 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (YM-90K; 10 μM), alone or in combination, was without effect. Incubation of striatal slices with 50 μM La<sup>3+</sup>
, which blocks voltage-dependent calcium channels, did not inhibit [<sup>3</sup>
H]dopamine release induced by ouabain. The potent effects of riluzole observed in this model are probably related to its ability to block voltage-dependent sodium channels. The consequences of this activity are critically discussed in relation to the protective action of riluzole previously reported in various models of Parkinson's disease and other neurodegenerative disorders.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-3573</s0>
</fA01>
<fA02 i1="01"><s0>JPPMAB</s0>
</fA02>
<fA03 i2="1"><s0>J. pharm. pharmacol.</s0>
</fA03>
<fA05><s2>50</s2>
</fA05>
<fA06><s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>BOIREAU (A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MEUNIER (M.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>IMPERATO (A.)</s1>
</fA11>
<fA14 i1="01"><s1>Rhône-Poulenc Rorer S. A., Centre de Recherche de Vitry-Alfortville, 13, quai Jules Guesde BP 14</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>1293-1297</s1>
</fA20>
<fA21><s1>1998</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>984</s2>
<s5>354000072887810140</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>30 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>99-0043435</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Journal of pharmacy and pharmacology</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We have examined the effects of riluzole, a neuroprotective drug which stabilizes voltage-dependent sodium channels in their inactivated state and inhibits the release of glutamate in-vivo and in-vitro, on the release of newly taken up [<sup>3</sup>
H]dopamine induced by ouabain, a potent and selective inhibitor of Na<sup>+</sup>
/K<sup>+</sup>
-ATPase in mouse striatal slices in-vitro. Riluzole potently (IC50 (concentration resulting in 50% inhibition)=0.9±0.3 μM) and dose-dependently antagonized ouabain-stimulated [<sup>3</sup>
H]dopamine release, the effect being observed at low concentrations. Tetrodotoxin (1 μM) and nomifensine (10 μM) also abolished ouabain-induced [<sup>3</sup>
H]dopamine release. Blockade of glutamate receptors with dizocilpine (1 μM) and 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (YM-90K; 10 μM), alone or in combination, was without effect. Incubation of striatal slices with 50 μM La<sup>3+</sup>
, which blocks voltage-dependent calcium channels, did not inhibit [<sup>3</sup>
H]dopamine release induced by ouabain. The potent effects of riluzole observed in this model are probably related to its ability to block voltage-dependent sodium channels. The consequences of this activity are critically discussed in relation to the protective action of riluzole previously reported in various models of Parkinson's disease and other neurodegenerative disorders.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02B10</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Riluzole</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Riluzole</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Riluzol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Anticonvulsivant</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Anticonvulsant</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Anticonvulsivante</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Psychotrope</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Psychotropic</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Psicotropo</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Activité biologique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Biological activity</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Actividad biológica</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Mécanisme action</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Mechanism of action</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Mecanismo acción</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Animal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Animal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Animal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Souris</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Mouse</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Ratón</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Système nerveux central</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Central nervous system</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Sistema nervioso central</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Corps strié</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Corpus striatum</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Cuerpo estriado</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>In vitro</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>In vitro</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>In vitro</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Catécholamine</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Catecholamine</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Catecolamina</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Neurotransmetteur</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Neurotransmitter</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Neurotransmisor</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Antagoniste calcium</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Calcium antagonist</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Antagonista calcio</s0>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Neuroprotecteur</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Neuroprotective agent</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Neuroprotector</s0>
<s5>21</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Canal ionique</s0>
<s5>22</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Ionic channel</s0>
<s5>22</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Canal iónico</s0>
<s5>22</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>23</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>23</s5>
</fC03>
<fC03 i1="17" i2="X" l="GER"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>23</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Calcio</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>23</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE"><s0>Benzothiazole</s0>
<s5>25</s5>
</fC03>
<fC03 i1="18" i2="X" l="ENG"><s0>Benzothiazole</s0>
<s5>25</s5>
</fC03>
<fC03 i1="18" i2="X" l="SPA"><s0>Benzotiazol</s0>
<s5>25</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fN21><s1>025</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Vitry-sur-Seine</li>
</settlement>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A." last="Boireau">A. Boireau</name>
</region>
<name sortKey="Imperato, A" sort="Imperato, A" uniqKey="Imperato A" first="A." last="Imperato">A. Imperato</name>
<name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M." last="Meunier">M. Meunier</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001428 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001428 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:99-0043435 |texte= Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |